Globus Medical (GMED) Tops Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical Reports Full Year and Fourth Quarter 2015 Results
February 24, 2016 4:50 PM ESTAUDUBON, Pa., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the fourth quarter and year ended December 31, 2015.
Fourth Quarter:
Worldwide sales increased 10.7% as reported to $142.6 million, or 11.5% on a constant currency basisFourth quarter net income was $37.6 millionEarnings per fully diluted share were $0.39Non-GAAP Adjusted EBITDA was 37.7% of salesFull Year 2015:
Worldwide sales increased 14.8% as reported to $544.8 million, or 16.0% on a constant currency basisNet income... More